BioSpace News Archive

Samsara BioCapital, a leading life sciences investment firm, Evotec SE, a global drug discovery alliance and development partnership company, and KCK Ltd., a family investment fund, announced the launch of Autobahn Labs, a novel virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development.

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today it has completed patient enrollment in it

Includes positive clinical findings from a postcoital test (PCT) human clinical study of Ovaprene®, an investigational hormone-free, monthly contraceptive

, the National Institute for Innovation in Manufacturing Biopharmacueticals announces that they have identified nine projects to allocate approximately $8.9 million from the U.S. Department of Commerce’s National Institute of Standards and Technology award received in May 2020 towards the support the nation’s response to the COVID-19 pandemic.

Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the Opto Antigen-Presenting Bead (APB) kit, a new reagent kit that activates and expands antigen-specific T cells in peripheral blood to create artificial T cells.

CorTechs Labs and Subtle Medical join together to increase global access to medical imaging solutions. The non-exclusive business development agreement expands Subtle Medical’s automated image reconstruction solutions to CorTechs Labs’ global customer base via its internal sales and marketing teams.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced new scientific findings have been highlighted today in a Science Translational Medicine cover publication.

Acceleron Pharma Inc. (NASDAQ:XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today presented topline results of the PULSAR Phase 2 trial of sotatercept in patients with pulmonary arterial hypertension (PAH).

BrainsWay Ltd., a global leader in the advanced non-invasive treatment of brain disorders, reported financial results for the quarter ended March 31, 2020, and provided an operational update.

The Association for the Accreditation of Human Research Protection Programs announced that it has awarded full accreditation to Western Michigan University Homer Stryker M.D. School of Medicine.